Evaluation of the effect of treatment with DPP-4 inhibitor on endothelial function versus sulphonylurea on markers of oxidative stress and inflammation and platelet function in patients with diabetes mellitus type 2 in primary failure with metformin and with HbA1c values below 8, 5% [valutazione dell'effetto del terapia con inibitore del dpp-4 vs sulfanilurea sulla funzione endoteliale sui marcatori di stress ossidativo e di infiammazione e sulla funzionalita' piastrinica in paziente con diabete mellito tipo 2 in fallimento primario con metformina e con valori di Hba1c inferiori a 8, 5%]

Trial Profile

Evaluation of the effect of treatment with DPP-4 inhibitor on endothelial function versus sulphonylurea on markers of oxidative stress and inflammation and platelet function in patients with diabetes mellitus type 2 in primary failure with metformin and with HbA1c values below 8, 5% [valutazione dell'effetto del terapia con inibitore del dpp-4 vs sulfanilurea sulla funzione endoteliale sui marcatori di stress ossidativo e di infiammazione e sulla funzionalita' piastrinica in paziente con diabete mellito tipo 2 in fallimento primario con metformina e con valori di Hba1c inferiori a 8, 5%]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Sitagliptin (Primary) ; Sulfonylureas
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top